Showing results (311-320 of 404) with videos related to

Sort By:
Pageof 41
Schizophrenia Research|August 28, 2022
Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosisOlga Santesteban-Echarri, Lu Liu, Madeline Miller, et al.
JAMA Psychiatry|November 3, 2016
Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal StudyLarry J Seidman, Daniel I Shapiro, William S Stone, et al.
Frontiers in Psychiatry|May 8, 2023
Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosisCarolyn M Amir, Simon Kapler, Gil D Hoftman, et al.
Psychiatry Research|March 4, 2022
Family history of psychosis in youth at clinical high risk: A replication studyOlga Santesteban-Echarri, Danah Sandel, Lu Liu, et al.
Development and Psychopathology|April 20, 2017
Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosisEva Velthorst, Jamie Zinberg, Jean Addington, et al.
Schizophrenia Research|November 2, 2020
Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcomeRicardo E Carrión, Andrea M Auther, Danielle McLaughlin, et al.
Schizophrenia Bulletin|September 5, 2015
A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month OutcomesDelbert G Robinson, Juan A Gallego, Majnu John, et al.
Schizophrenia Research|March 1, 2023
Ethnoracial discrimination and the development of suspiciousness symptoms in individuals at clinical high-risk for psychosisTimothy I Michaels, Ricardo E Carrión, Jean Addington, et al.
Schizophrenia Bulletin|March 21, 2026
The Utility of Negative Symptoms in Predicting Transition to Psychosis Among Individuals at Clinical High RiskMitchell D Arnovitz, Barbara A Cornblatt, Andrea M Auther, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 18, 2026
Cannabis and Tobacco Co-Use is Associated with Impaired Neurocognitive Performance in Individuals at Clinical High Risk for PsychosisDaniel Bello, Jillian G Connolly, Jean Addington, et al.
Pageof 41